QuickView for Cytochrome b5, heme-binding site (biogroup)

1. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP - Non-small cell lung cancer A549.311 cells with CRISPR targeted gene knockouts

There were no matches for Cytochrome b5, heme-binding site

There were no clinical trials for Cytochrome b5, heme-binding site